Zimmer Biomet Holdings Inc

NYSE:ZBH   4:00:00 PM EDT
127.65
-0.15 (-0.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)26.59B
Current PE58.99
Forward PE 17.16
2yr Forward PE 16.06
See more stats
Estimates Current Quarter
Revenue$1.82 Billion
Adjusted EPS$1.81
See more estimates
10-Day MA$130.97
50-Day MA$132.85
200-Day MA$121.42
See more pivots

Zimmer Biomet Holdings Inc Stock, NYSE:ZBH

345 East Main Street, Warsaw, Indiana 46580
United States of America
Phone: +1.574.267.6131
Number of Employees: 18000

Description

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. The company operates through the following segments: Americas Orthopedics, EMEA, Asia Pacific, and Americas Spine and Global Dental. The Americas Orthopedics segment consists of the U.S. market and includes other North, Central, and South American markets for the firm�s orthopedic product categories. The EMEA segment focuses on Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment consists of Japan, China, and Australia and includes other Asian and Pacific markets for all product categories except Dental. The Americas Spine and Global Dental segment focuses on the U.S. market and includes other North, Central, and South American markets for the firm's spine business, and all geographic markets for its dental business. This segment is also involved in research, development engineering, medical education, and brand management. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.